J. DONALD EASTON, M.D.
This content is PDF only. Please click on the PDF icon to access.
Diphenylhydantoin (phenytoin; Dilantin®) ranks with the barbiturates in being one of the most commonly used drugs in the management of seizure disorders. In fact, diphenylhydantoin has been recommended for the treatment of a vast array of neurological disorders and neuropsychiatric symptoms (1). One of the hydantoins, Nirvanol® (5-ethyl-5-phenylhydantoin), was used in the 1920s for the treatment of Sydenham's chorea, but they did not come into widespread clinical use until the late 1930s, when Merritt and Putnam introduced diphenylhydantoin as an anticonvulsant. Since that time a wide spectrum of side effects have been attributed to diphenylhydantoin; they range from rather benign
EASTON JD. Potential Hazards of Hydantoin Use. Ann Intern Med. 1972;77:998–999. doi: 10.7326/0003-4819-77-6-998
Download citation file:
Published: Ann Intern Med. 1972;77(6):998-999.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use